We are honored to share that the Furnari Lab has been awarded two research grants from Curebound, supporting our ongoing efforts to better understand and treat malignant brain tumors such as glioblastoma. These grants will help advance projects focused on uncovering the molecular and microenvironmental drivers of tumor progression and therapy resistance, with the goal of identifying new strategies that can ultimately benefit patients and families affected by brain cancer.

​

We are deeply grateful to Curebound for their commitment to accelerating cancer research and for believing in the impact of our work. This support strengthens our lab’s mission to bridge fundamental discovery with meaningful clinical progress in neuro-oncology.